Dr. Fady Sinno, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5300 Dorsey Hall Dr, Ste 102, Ellicott City, MD 21042 Phone: 410-884-4200 Fax: 410-715-8534 |
Terri Lynn Hill, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4785 Dorsey Hall Dr, Suite 111, Ellicott City, MD 21042 Phone: 410-992-9600 Fax: 410-992-9641 |
Dr. Mitchel Allen Kanter, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5092 Dorsey Hall Dr, Suite 102, Ellicott City, MD 21042 Phone: 410-715-9205 |
Dr. William Ralph Kanter, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5092 Dorsey Hall Dr, Suite 102, Ellicott City, MD 21042 Phone: 410-715-9205 |
News Archive
Debbie Cook was in her pajamas on a summer morning in 2019 when she got a call from her son: "Something bad is wrong with Granny."
'Tis the season of merriment, cheer and overindulgence. If your holiday season usually turns into a new year that includes a few extra pounds, you can prevent holiday weight gain with these 10 tips from the team of medical experts at Greenwich Hospital's Weight Loss & Diabetes Center.
Parkinson's disease (PD), a severely crippling disease of the nerves and brain has been linked to genes that affect the immune system according to new research. In these patients the immune system may go awry attacking healthy tissues or failing to fight infections that leave people susceptible to the condition scientists say.
A recent study by researchers from Beth Israel Deaconess Medical Center and Harvard Medical School, currently available on the preprint server medRxiv, demonstrates how nasal swab samples reliably detect patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that present with high viral loads, but may miss many patients with lower viral loads – questioning their role as a sole specimen for diagnostic purposes.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
› Verified 9 days ago